In vitro and in vivo anti-platelet effects of enzymatic hydrolysates of collagen and collagen-related peptides

被引:18
作者
Nonaka, I
Katsuda, SI
Ohmori, T
Shigehisa, T
Nakagami, T
Maruyama, S
机构
[1] NIPPON MEAT PACKERS INC, CTR RES & DEV, DEPT HLTH & DIETARY SCI, TSUKUBA, IBARAKI 30026, JAPAN
[2] NATL INST BIOSCI & HUMAN TECHNOL, AGCY IND SCI & TECHNOL, TSUKUBA, IBARAKI 305, JAPAN
关键词
collagen; collagenase; collagen-related synthetic peptide; fibrinogen; thrombin;
D O I
10.1271/bbb.61.772
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Collagen-related peptides, Gly-Pro-Arg and its analogues,, were examined for their inhibitory effects on platelet aggregation induced by the addition of ADP. Human platelet aggregation was suppressed by more than 50% with each of Gly-Pro-Arg and such Gly-Pro-Arg-containing peptides as Gly-Pro-Arg-Gly, Gly-Pro-Arg-Gly-Pro, Gly-Pro-Arg-Pro-Pro, and Gly-Pro-Arg-Pro-Pro-Pro at a concentration of 0.3 mar. The inhibitory effects of these peptides were about 10 times higher in human PRP than in rat PRP, Other Gly-Pro-Arg analogues such as Sar-Pro-Arg, Gly-Pro-Lys, Gly-Ala-Arg, and Ala-Gly-Pro-Arg had no inhibitory effect at a concentration from 0.1 to 0.8 mM even in human PRP. Intravenous and oral administrations of Gly-Pro-Arg and enzymatic hydrolysates of collagen suppressed the decrease in platelet count for endotoxin-induced DIC in rats, Collagen itself has been regarded as a potent inducer of platelet aggregation, but these findings suggest that collagen-related peptides and enzymatic hydrolysates of collagen prevent platelet aggregation.
引用
收藏
页码:772 / 775
页数:4
相关论文
共 22 条
[11]  
MARGARETTEN W, 1964, LAB INVEST, V13, P552
[12]   INHIBITORY EFFECTS OF ENZYMATIC HYDROLYSATES OF COLLAGEN AND COLLAGEN-RELATED SYNTHETIC PEPTIDES ON FIBRINOGEN THROMBIN CLOTTING [J].
MARUYAMA, S ;
NONAKA, I ;
TANAKA, H .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1164 (02) :215-218
[13]   SPECIES VARIATION IN THE EFFECT OF GLYCOPROTEIN-IIB/IIIA ANTAGONISTS ON INHIBITION OF PLATELET-AGGREGATION [J].
PANZERKNODLE, S ;
TAITE, BB ;
MEHROTRA, DV ;
NICHOLSON, NS ;
FEIGEN, LP .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1993, 30 (01) :47-53
[14]   FIBRINOGEN, FIBRINOGEN RECEPTORS, AND THE PEPTIDES THAT INHIBIT THESE INTERACTIONS [J].
PLOW, EF ;
MARGUERIE, G ;
GINSBERG, M .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (23) :4035-4040
[15]   INHIBITION OF FIBRINOGEN BINDING TO HUMAN-PLATELETS BY THE TETRAPEPTIDE "GLYCYL-L-PROLYL-L-ARGINYL-L-PROLINE [J].
PLOW, EF ;
MARGUERIE, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (12) :3711-3715
[16]  
SAVAGE B, 1990, J BIOL CHEM, V265, P11766
[17]  
SCHOENDORF TH, 1971, AM J PATHOL, V65, P51
[18]  
SHEU JR, 1994, J LAB CLIN MED, V123, P256
[19]   ANTIHAEMOSTATIC AND ANTITHROMBOTIC EFFECT OF SOME ANTIPLATELET AGENTS ISOLATED FROM CHINESE HERBS [J].
TENG, CM ;
KO, FN ;
WANG, JP ;
LIN, CN ;
WU, TS ;
CHEN, CC ;
HUANG, TF .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (09) :667-669
[20]  
WALTER R, 1980, MOL CELL BIOCHEM, V30, P111